All news | PDC*line Pharma

About us
- Back
- About us
- Our mission
- Our Team
Technology
- Back
- Technology
- PDC*vac technology
- Competitive Advantages
- Intellectual property
- Key publications
- Posters
Pipeline
- Back
- Pipeline
- Product pipeline
- Melanoma
- Lung Cancer
Clinical trials
- Back
- Clinical trials
- PDC*Mel
- PDC*Lung
Investors
- Back
- Investors
- Company profile
- Investment opportunity
News
Contact
Jobs
Videos

About us
- Our mission
- Our Team
Technology
Pipeline
Clinical trials
- PDC*Mel
- PDC*Lung
Investors
- Company profile
- Investment opportunity
News
Contact
Jobs
Videos

Biovision Investor Conference

June 2014

PDC*line Pharma has been selected to present at Biovision Investor Conference on June 5, 2014.

Events

GeniusVac-Mel4

August 2013

Grenoble CHU and EFS started the clinical trial GeniusVac-Mel4.Read the article

Press releases

Pagination

Previous page
You're on Page 10

Partners

R & D

EFS
(Etablissement Français du Sang – French Blood Bank) transferred the PDC*vac technology to PDC*line Pharma, and provides us with privileged access to its research and GMP-compliant manufacturing infrastructures.

Website

CHU Grenoble
University teaching hospital of Grenoble is sponsor of the phase 1 clinical trial of PDC*mel in advanced melanoma.

Website

Support

Public Service of Wallonia (BELGIUM) – DGO6 Research and Innovation is a Departement of the wallonian Administration that promote wallonian industrial companies to finance their research and innovation programs with a series of financial grants and loans.